Belluscura Initiates Strategic Review to Address Funding Needs
The medical device company is launching a strategic review to address its funding needs, as it faces product sourcing challenges and seeks to strengthen its capital position.
The medical device company is launching a strategic review to address its funding needs, as it faces product sourcing challenges and seeks to strengthen its capital position.
The medical device developer reports a substantial increase in Q1 sales and the launch of a new portable oxygen concentrator, despite some tariff-related challenges.
The healthcare company has announced a change in director shareholding.
The healthcare company has announced a change in its shareholding structure.
The medical device company reports a change in major shareholding, with no significant implications.
The medical device company has announced a change in major shareholding, with Dowgate Group Limited reducing its stake in the business.
The medical device company has announced a change in major shareholding, with a director reducing their stake.
The medical device company has announced a change in major shareholding, with Cantor Fitzgerald Europe reducing its stake in the firm.
The medical device company has announced a change in major shareholding, with Dowgate Group Limited increasing its stake in the business.
The healthcare company has announced a director has increased their stake in the business.